BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33250962)

  • 1. Influence of primary tumor location and resection on survival in metastatic colorectal cancer.
    Tharin Z; Blanc J; Alaoui IC; Bertaut A; Ghiringhelli F
    World J Gastrointest Oncol; 2020 Nov; 12(11):1296-1310. PubMed ID: 33250962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.
    van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M
    Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
    Wong SF; Wong HL; Field KM; Kosmider S; Tie J; Wong R; Tacey M; Shapiro J; Nott L; Richardson G; Cooray P; Jones I; Croxford M; Gibbs P
    Clin Colorectal Cancer; 2016 Sep; 15(3):e125-32. PubMed ID: 26803709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis.
    Yao YC; Chen JQ; Yin L; Lin WH; Peng JH; Fan WH
    BMC Gastroenterol; 2022 Mar; 22(1):114. PubMed ID: 35264117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study.
    Kawamura H; Ogawa Y; Yamazaki H; Honda M; Kono K; Konno S; Fukuhara S; Yamamoto Y
    World J Surg; 2021 Oct; 45(10):3230-3239. PubMed ID: 34223985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
    Ergun Y; Bal O; Dogan M; Ucar G; Dirikoc M; Acikgoz Y; Bacaksiz F; Uncu D
    J Res Med Sci; 2020; 25():14. PubMed ID: 32174986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase 3 CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.
    van der Kruijssen DEW; Elias SG; van de Ven PM; van Rooijen KL; Lam-Boer J'; Mol L; Punt CJA; Sommeijer DW; Tanis PJ; Nielsen JD; Yilmaz MK; Van Riel JMGH; Wasowiz-Kemps DK; Loosveld OJL; van der Schelling GP; de Groot JWB; van Westreenen HL; Jakobsen HL; Fromm AL; Hamberg P; Verseveld M; Jaensch C; Liposits GI; van Duijvendijk P; Hadj JO; van der Hoeven JAB; Trajkovic M; de Wilt JHW; Koopman M;
    Ann Oncol; 2024 Jun; ():. PubMed ID: 38852675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery.
    Li XF; Tan YN; Zhong CH; Zhu LZ; Fang XF; Li J; Ding KF; Yuan Y
    Oncotarget; 2017 Oct; 8(45):79618-79628. PubMed ID: 29108341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative resection of the primary tumour improves survival in incurable metastatic colorectal cancer.
    Inci K; Nilsson B; Lindskog S; Giglio D
    ANZ J Surg; 2023 Nov; 93(11):2680-2685. PubMed ID: 37489624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
    Fanotto V; Rossini D; Casagrande M; Bergamo F; Spagnoletti A; Santini D; Antoniotti C; Cupini S; Daniel F; Nasca V; Vetere G; Zaniboni A; Borelli B; Carullo M; Conca V; Passardi A; Tamburini E; Masi G; Pella N; Cremolini C
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.
    van der Kruijssen DEW; Elias SG; Vink GR; van Rooijen KL; 't Lam-Boer J; Mol L; Punt CJA; de Wilt JHW; Koopman M;
    JAMA Surg; 2021 Dec; 156(12):1093-1101. PubMed ID: 34613339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.
    Yeom SS; Lee SY; Kwak HD; Kim CH; Kim YJ; Kim HR
    Medicine (Baltimore); 2020 Feb; 99(7):e19258. PubMed ID: 32049866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
    Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
    Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience.
    de Mestier L; Neuzillet C; Pozet A; Desot E; Deguelte-Lardière S; Volet J; Karoui M; Kianmanesh R; Bonnetain F; Bouché O
    Eur J Surg Oncol; 2014 Jun; 40(6):685-91. PubMed ID: 24630774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.
    Wang Z; Liang L; Yu Y; Wang Y; Zhuang R; Chen Y; Cui Y; Zhou Y; Liu T
    Cell Physiol Biochem; 2016; 39(3):1239-46. PubMed ID: 27595400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysis.
    Ramadan M; Alfayea T; Alsofyani A; Alyabsi M; Alhusseini N; Algarni AS
    Cancer Treat Res Commun; 2022; 33():100632. PubMed ID: 36088745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Primary Tumor Site With Mortality in Patients Receiving Bevacizumab and Cetuximab for Metastatic Colorectal Cancer.
    Aljehani MA; Morgan JW; Guthrie LA; Jabo B; Ramadan M; Bahjri K; Lum SS; Selleck M; Reeves ME; Garberoglio C; Senthil M
    JAMA Surg; 2018 Jan; 153(1):60-67. PubMed ID: 28975237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Tumor Resection Provides Survival Benefits for Patients with Synchronous Brain Metastases from Colorectal Cancer.
    Cheng X; Li Y; Chen D; Xu X; Liu F; Zhao F
    Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of first line chemotherapy strategy depending on primary tumor location in metastatic colorectal cancer.
    Tharin Z; Blanc J; Alaoui IC; Bertaut A; Ghiringhelli F
    J Gastrointest Oncol; 2021 Aug; 12(4):1509-1517. PubMed ID: 34532106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer: A Population-Based Study.
    van der Kruijssen DEW; Brouwer NPM; van der Kuil AJS; Verhoeven RHA; Elias SG; Vink GR; Punt CJA; de Wilt JHW; Koopman M
    Am J Clin Oncol; 2021 Jul; 44(7):315-324. PubMed ID: 33899807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.